GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bioray Biotech Co Ltd (ROCO:7561) » Definitions » EBITDA Margin %

Bioray Biotech Co (ROCO:7561) EBITDA Margin % : 1.52% (As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Bioray Biotech Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Bioray Biotech Co's EBITDA for the six months ended in Jun. 2024 was NT$1.3 Mil. Bioray Biotech Co's Revenue for the six months ended in Jun. 2024 was NT$85.8 Mil. Therefore, Bioray Biotech Co's EBITDA margin for the quarter that ended in Jun. 2024 was 1.52%.


Bioray Biotech Co EBITDA Margin % Historical Data

The historical data trend for Bioray Biotech Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioray Biotech Co EBITDA Margin % Chart

Bioray Biotech Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial 21.05 9.59 9.37 12.74 6.33

Bioray Biotech Co Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.44 12.12 6.11 6.54 1.52

Competitive Comparison of Bioray Biotech Co's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Bioray Biotech Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioray Biotech Co's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bioray Biotech Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Bioray Biotech Co's EBITDA Margin % falls into.


;
;

Bioray Biotech Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Bioray Biotech Co's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=12.135/191.83
=6.33 %

Bioray Biotech Co's EBITDA Margin % for the quarter that ended in Jun. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=1.303/85.795
=1.52 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bioray Biotech Co  (ROCO:7561) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Bioray Biotech Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Bioray Biotech Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioray Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1, Dali 2nd Road, Southern Science Park, Shanhua District, Tainan, TWN, 90846
Bioray Biotech Co Ltd is engaged in the development and manufacturing of biological agents, including functional probiotics, medicinal fungi, and immune cell preparations. The company provides capsules, powders, lozenges, and liquids for Skincare, Anti-aging and anti-inflammatory, Silver Hair Maintenance, and Microbe and mineral supplement among others.

Bioray Biotech Co Headlines

No Headlines